Elbecta S 500mg/250mg Injection
Marketer
Elcliff Formulations Pvt Ltd
Salt Composition
Ceftriaxone (500mg) + Sulbactam (250mg)
Overview Elbecta S 500mg/250mg Injection
Combiflox 500mg/250mg Injection, a dual-action antibiotic, combats diverse bacterial infections by hindering microbial proliferation and halting infection spread. Administration must be solely under a doctor's guidance; strict adherence to the prescribed regimen is crucial, even with symptom improvement, as premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and indigestion; worsening symptoms warrant immediate medical attention. Seek immediate help for allergic reactions (e.g., rash, itching, swelling, dyspnea). Inform your physician of all current medications, including those for pre-existing conditions, prior to use. Pregnant or lactating individuals require medical consultation before initiating treatment. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, drowsiness or dizziness necessitates abstaining from driving. Adequate rest, nutritious food, and sufficient hydration are recommended for optimal recovery. Your doctor may order laboratory tests to monitor the medication's effects.
Primary Ingredients of Elbecta S 500mg/250mg Injection
No text provided to rephrase.
Uses of Elbecta S 500mg/250mg Injection
Infections caused by bacteria
Major Benefits of Elbecta S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Elbecta S 500mg/250mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Elbecta S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Elbecta S 500mg/250mg Injection works:
Elbecta S Injection (500mg/250mg) combines the antibiotic ceftriaxone with the beta-lactamase inhibitor sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, a crucial process for bacterial viability. Sulbactam counters bacterial resistance, thereby boosting ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Elbecta S 500mg/250mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Elbecta S 500mg/250mg is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
The use of Elbecta S 500mg/250mg Injection while breastfeeding requires careful consideration. Mothers should discontinue breastfeeding throughout the treatment period and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Elbecta S 500mg/250mg Injection might induce drowsiness, blurred vision, or dizziness. Driving is inadvisable if these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Elbecta S 500mg/250mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
The injectable formulation Elbecta S 500mg/250mg requires careful administration in individuals with advanced hepatic impairment; dosage modification may be necessary. Physician consultation is advised. Altering the dosage of Elbecta S 500mg/250mg Injection is unnecessary for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Elbecta S 500mg/250mg Injection :
Should you forget a scheduled dose of Elbecta S 500mg/250mg Injection, seek medical advice.
Facts to Know About Elbecta S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently